Evaluation of whether adjuvant chemotherapy can be safely omitted for older female patients with ER-positive, HER2-negative N1 breast cancer: a study based on the SEER database

BACKGROUND: This study evaluated the trends and practice patterns associated with adjuvant chemotherapy (CT) use for patients aged ≥70 years with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2–) N1 (1–3 positive lymph nodes) breast cancer (BC). Furthermore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Minhao, Yuan, Peng, Ma, Youzhao, Tian, Peiqi, Chen, Xiuchun, Liu, Zhenzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339850/
https://www.ncbi.nlm.nih.gov/pubmed/34422994
http://dx.doi.org/10.21037/atm-21-3097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339850/
https://www.ncbi.nlm.nih.gov/pubmed/34422994
http://dx.doi.org/10.21037/atm-21-3097

Ejemplares similares